Lorven Biologics Private Limited, a active private limited company, was established on 09 October 2015 in Srikakulam, Andhra Pradesh, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U74120AP2015PTC097532. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.20 Cr.
It upholds a compliant status. Its leadership includes Srikanth Reddy Devireddy (Director), Venkataramana Mudili (Managing Director), Rahul Kumar Peraka (Director). Past directors included Pradeep Moses Mathi, Devi Kalyan Kumar Thakasi, Amarendra Bussa. It holds ₹9.79 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Modugulapeta Village,Govindapuram Post Santhakavitri Mandal, Srikakulam, Andhra Pradesh, 532123.
U74120AP2015PTC097532
097532
09 October 2015
₹10.00 Cr
₹9.20 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Lorven Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srikanth Reddy Devireddy | Director | 03 Jul 2023 | Current |
| Venkataramana Mudili | Managing Director | 09 Oct 2015 | Current |
| Rahul Kumar Peraka | Director | 01 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Oct 2018 | Past |
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
| Pramod Abcsdd | Director | 02 Nov 2018 | Past |
| Pramod Abcsdd | Director | 07 Oct 2019 | Past |
| Pramod Abcsdd | Director | 07 Sep 2021 | Past |
| Pramod Abcsdd | Director | 04 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lorven Biologics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.89% increase. The company also saw a substantial fall in profitability, with a 40.46% decrease in profit. The company's net worth Soared by an impressive increase of 237.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lorven Biologics had a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹97,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2025 | Others | ₹1.29 Cr | Open |
| 30 Mar 2024 | State Bank Of India | ₹5.50 Cr | Open |
| 21 Oct 2021 | Sidbi | ₹2.00 Cr | Open |
| 01 Jul 2021 | Sidbi | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lorven Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lorven Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lorven Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 101148384 was registered on 29 Jun 2025. was recorded as a recent event.
Progress on Lorven Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Lorven Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 5.50 Cr with Charge ID 100902418 was registered on 30 Mar 2024. was documented.
Progress on Srikanth Reddy Devireddy was appointed as a Director was appointed as a Director on 03 Jul 2023 & has been associated with this company since 2 years 6 months . was documented.
Progress on A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100490000 was registered on 21 Oct 2021. was documented.
The CIN of Lorven Biologics Private Limited is U74120AP2015PTC097532.
Lorven Biologics Private Limited is headquartered at Modugulapeta Village,Govindapuram Post Santhakavitri Mandal, Srikakulam, Andhra Pradesh, 532123.
Lorven Biologics Private Limited was incorporated on 09 October 2015.
The current directors of Lorven Biologics Private Limited are
The primary industry of Lorven Biologics Private Limited is Professional, Scientific And Technical.
Lorven Biologics Private Limited is unlisted.
The authorized capital of Lorven Biologics Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.20 Cr.
The compliance status of Lorven Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX